Etiological and Resistance Profile of Bacteria Involved in Urinary Tract Infections in Young Children
Metadata
Show full item recordAuthor
Sorlozano Puerto, Antonio; Gómez Luque, José María; Luna Del Castillo, Juan De Dios; Navarro Mari, José María; Gutiérrez Fernández, JoséEditorial
Hindawi
Date
2017-04-11Referencia bibliográfica
Sorlózano-Puerto, A., Gómez-Luque, J. M., Luna-del-Castillo, J. D. D., Navarro-Marí, J. M., & Gutiérrez-Fernández, J. (2017). Etiological and resistance profile of bacteria involved in urinary tract infections in young children. BioMed research international, 2017.
Sponsorship
Parts of this work were supported by the CTS-521 research groupAbstract
The objective of this study was to identify the bacteria most frequently responsible for urinary tract infection (UTI) in
the population of under-2-year-olds in our geographic area and to evaluate the activity of antibiotics widely used for UTI treatment
during a 4-year study period. Materials and Methods. A retrospective analysis was conducted of data on the identification and
susceptibility of microorganisms isolated in urine samples from children under 2 years of age. A total of 1,045 uropathogens
were isolated. Escherichia coli accounted for the majority (60.3%) of these, followed by Enterococcus faecalis (22.4%) and Klebsiella
spp. (6.5%). The highest E. coli susceptibility rates (>90%) were to piperacillin-tazobactam, cefuroxime, cefotaxime, ceftazidime,
imipenem, gentamicin, nitrofurantoin, and fosfomycin, and the lowest were to amoxicillin-clavulanic acid and cotrimoxazole.
Among all bacteria isolated, we highlight the overall high activity of piperacillin-tazobactam, imipenem, nitrofurantoin, and
fosfomycin against both community and hospital isolates and the reduced activity of amoxicillin-clavulanic acid, cephalosporins,
gentamicin, and cotrimoxazole. There was no significant change in the total activity of any of the studied antibiotics over the 4-year
study period. Empiric treatment with amoxicillin-clavulanic acid, cotrimoxazole, cephalosporins, and gentamicin may
be inadequate due to their limited activity against uropathogens in our setting